Unlock instant, AI-driven research and patent intelligence for your innovation.

8-(benzothiazole amide) substituted coumarin compounds, and preparation method and application thereof

A technology of benzothiazolamide and coumarins, applied in the field of medicine, can solve problems such as side effects of patients, neuroprotective effect of Parkinson's disease, etc., and achieve good inhibitory activity, significant protective effect, and effect of preventing Parkinson's disease.

Active Publication Date: 2021-07-23
LONGIVITRON (SUZHOU) BIOTECHNOLOGY CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But no drug currently protects against degeneration of neurons in Parkinson's disease
Drugs for the treatment of Parkinson's disease (such as levodopa) on the market are mainly aimed at relieving the symptoms of the disease, and long-term use of such drugs will bring serious side effects to patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 8-(benzothiazole amide) substituted coumarin compounds, and preparation method and application thereof
  • 8-(benzothiazole amide) substituted coumarin compounds, and preparation method and application thereof
  • 8-(benzothiazole amide) substituted coumarin compounds, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0104] This preparation example prepares intermediate 3 shown in the following formula, and the synthetic route is:

[0105]

[0106] (1) Add n-butyllithium (1.60M n-hexane solution) (14.00mL, 22.33mmol) slowly to 8-bromocoumarin (5.00g, 22.33mmol) in anhydrous tetrahydrofuran at -78°C under nitrogen protection (30mL) solution. After stirring at -78 °C for 3 h, the solution was frozen in a liquid nitrogen bath and then vacuumed, followed by the introduction of 3 (5.29g, 26.80mmol) reacted with concentrated sulfuric acid (1.43mL, 26.80mmol) to generate CO 2 gas. The mixture was stirred at -78 °C for 2 h, then at 20 °C with saturated NH 4 Aqueous Cl solution quenched the reaction. The pH was adjusted to 5 with hydrochloric acid, extracted three times with ethyl acetate (15 mL×3), washed once with saturated brine, and the combined organic phases were dried over anhydrous sodium sulfate and concentrated. The product was purified by silica gel column to obtain coumarin-8-ca...

Embodiment 1

[0109] Compound 1 prepared in this example: N-(2-(4-chlorobenzyl)benzothiazol-4-yl)-2-oxo-2H-chromene-8-amide, its structure is as follows:

[0110]

[0111] A solution of 4-chlorobenzylmagnesium bromide in ether (3.00M, 2.81mL, 8.43mmol) was added dropwise to the stirred N-(2-chlorobenzo[d]thiazol-4-yl)-2- Oxo-2H-chromene-8-carboxamide (2.00 g, 5.62 mmol) in anhydrous dichloromethane (10 mL). After the dropwise addition was completed, the reaction solution was stirred at 0°C for 1 hour, and then water was slowly added dropwise while keeping the temperature of the reaction solution below 10°C. After returning to 20 °C, the reaction solution was diluted with 50 mL of water and dichloromethane (1:1) and passed through a celite pad. Concentrate the organic phase and purify on a silica gel column to obtain 0.62 g of a white solid product with a yield of 25%. The product is characterized as follows:

[0112] 1 H NMR (400MHz, CDCl 3 ):δ8.15-8.35(m,2H),7.63-7.79(m,5H),7.10-7....

Embodiment 2

[0115] Compound 2 prepared in this example: N-(2-(3-chlorobenzyl)benzothiazol-4-yl)-2-oxo-2H-chromene-8-amide, its structure is as follows:

[0116]

[0117] Prepare with reference to the preparation method in embodiment 1, replace 4-chlorobenzylmagnesium bromide with 0.65 g of white solid was obtained, the yield was 26%. The product is characterized as follows:

[0118] 1 H NMR (400MHz, CDCl 3 ):δ8.15-8.35(m,2H),7.63-7.79(m,5H),7.12-7.44(m,4H),6.02(m,1H),3.85(s,2H).

[0119] HR-MS(ESI):[M+H]+C 24 h 16 ClN 2 o 3 The calculated value of S is 447.0570, and the measured value is 447.0578.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to 8-(benzothiazole amide) substituted coumarin compounds, and a preparation method and application thereof. The structure of the 8-(benzothiazole amide) substituted coumarin compounds is represented by formula (I) shown in the specification, and a ring A in the formula (I) is independently selected from a phenyl group, a naphthyl group and a 5-14-membered aromatic heterocyclic group. The 8-(benzothiazole amide) substituted coumarin compounds provided by the invention are brand new compound structures and have relatively strong SIRT2 inhibitory activity, the in-vitro SIRT2 inhibitory activity IC50 of 18 compounds reaches a micromole level, and the 8-(benzothiazole amide) substituted coumarin compound has a remarkable protection effect on neuroma cells. Therefore, the compounds can be widely used for preparing medicines for treating and / or preventing diseases or symptoms related to too high SIRT2 activity or overexpression of SIRT2 or preparing medicines for treating and / or preventing Parkinson's disease, metabolic diseases and tumors.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to an 8-(benzothiazole amide) substituted coumarin compound and its preparation method and application, in particular to an 8-(benzothiazole amide capable of inhibiting the activity or expression of SIRT2 ) substituted coumarin compound and its preparation method and application. Background technique [0002] Parkinson's disease is a common neurodegenerative disease, and its main clinical manifestations are slowness of movement, muscle stiffness and resting tremor. The pathological changes of Parkinson's disease are mainly reflected in the degeneration and necrosis of dopaminergic neurons in the substantia nigra of the midbrain, and the resulting significant reduction of dopamine content in the striatum. People with Parkinson's disease are burdened physically and psychologically. But there are currently no drugs that can protect against the degeneration of nerve cells...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D417/12C07D417/14A61K31/428A61K31/4709A61P25/16A61P3/00A61P35/00
CPCC07D417/12C07D417/14A61P25/16A61P3/00A61P35/00
Inventor 张小曦
Owner LONGIVITRON (SUZHOU) BIOTECHNOLOGY CO LTD